Invention Grant
- Patent Title: Antibody
-
Application No.: US15751574Application Date: 2016-08-02
-
Publication No.: US10654931B2Publication Date: 2020-05-19
- Inventor: Naoki Hosen , Haruo Sugiyama , Atsushi Kumanogoh , Junichi Takagi
- Applicant: OSAKA UNIVERSITY
- Applicant Address: JP Suita-shi, Osaka
- Assignee: OSAKA UNIVERSITY
- Current Assignee: OSAKA UNIVERSITY
- Current Assignee Address: JP Suita-shi, Osaka
- Agency: Sughrue Mion, PLLC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@e0b862e
- International Application: PCT/JP2016/072688 WO 20160802
- International Announcement: WO2017/026331 WO 20170216
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/00 ; C07K19/00 ; C12N5/10 ; C12N5/09 ; A61K35/17 ; C12N15/09 ; A61P35/00 ; C07K16/30
Abstract:
Provided is an active ingredient of a pharmaceutical composition for treating myeloma. Specifically, provided is an antibody whose epitope is present in the region of the amino acid residue positions 20 to 109 of human integrin β7.
Public/Granted literature
- US20180230216A1 ANTIBODY Public/Granted day:2018-08-16
Information query
